Unity Biotechnology, Inc

(NASDAQ:UBX)

Latest On Unity Biotechnology, Inc (UBX):

Date/Time Type Description Signal Details
2023-05-09 19:18 ESTNewsUnity Biotechnology GAAP EPS of -$0.76N/A
2023-04-11 19:43 ESTNewsUnity Biotech's chief medical officer Jamie Dananberg to exit companyN/A
2023-03-27 21:47 ESTNewsUnity Biotech sheds 48% after mid-stage setback for wet AMD candidateN/A
2023-03-15 18:01 ESTNewsUnity Biotechnology Non-GAAP EPS of -$1.00N/A
2023-03-05 13:00 ESTNewsUnity Biotechnology: One Last Chance With UBX1325N/A
2022-11-08 20:26 ESTNewsUnity Biotechnology GAAP EPS of -$1.36 misses by $0.30N/A
2022-11-01 16:46 ESTNewsUNITY Biotech up 27% on mid-stage data from diabetic macular edema treatmentN/A
2022-10-24 13:36 ESTNewsUnity Biotechnology: Share Consolidation On The Back Of Positive Trial ResultsN/A
2022-10-19 15:42 ESTNewsUNITY Biotechnology falls 7% on reverse stock splitN/A
2022-08-20 16:17 ESTNewsUnity Biotechnology cuts stock sales agreement in half to $25MN/A
2022-08-19 02:51 ESTNewsUNITY Biotechnology trades lower on pricing upsized $45.0M securities offeringN/A
2022-08-17 08:15 ESTNewsUnity Biotech sheds 9% on $25M common stock offeringN/A
2022-08-15 22:56 ESTNewsUnity extends gains on data for lead asset in diabetic macular edemaN/A
2022-08-15 22:55 ESTNewsUnity Biotechnology, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-12 09:07 ESTNewsUnity Biotech jumps 93% after data for lead asset in diabetic macular edemaN/A
2022-08-12 09:07 ESTNewsUnity Biotechnology GAAP EPS of -$0.19 beats by $0.10, revenue of $0.24MN/A
2022-05-11 11:36 ESTNewsUnity Biotechnology GAAP EPS of -$0.28N/A
2022-04-19 12:06 ESTNewsUNITY Biotech doses first patient in phase 2 study of UBX1325 for chronic eye disorder wAMDN/A
2022-03-16 14:08 ESTNewsUnity Biotechnology files for $125M mixed shelf offering; shares up 19%N/A
2022-03-15 10:49 ESTNewsUnity Biotechnology GAAP EPS of -$0.18 beats by $0.18, revenue of $4.78MN/A
2022-03-05 06:16 ESTNewsUnity Biotechnology (UBX) Investor Presentation - SlideshowN/A
2022-02-14 15:52 ESTNewsUNITY posts 24-week data from Phase 1 trial for UBX1325 in vascular eye diseasesN/A
2022-02-03 18:50 ESTNewsUNITY Biotech announces initiation of restructuring programN/A
2021-11-10 17:31 ESTNewsUnity Biotechnology EPS beats by $0.09N/A
2021-11-10 17:30 ESTNewsUnity Biotechnology posts biggest intraday gain after Q3 earningsN/A
2021-10-12 14:43 ESTNewsWarning: UBX is at high risk of performing badlyN/A
2021-10-06 19:56 ESTNewsUBX is at high risk of performing badlyN/A
2021-10-05 17:39 ESTNewsUnity Bio gains 5% on positive UBX1325 data from early-stage vascular eye disease studyN/A
2021-09-28 03:59 ESTNewsWarning: UBX has been downgraded to Very BearishN/A
2021-09-23 14:31 ESTNewsWarning: UBX has been downgraded to Very Bearish.N/A
2021-08-11 09:45 ESTNewsUnity Biotechnology EPS misses by $0.03N/A
2021-07-26 23:46 ESTNewsA Look At Unity's UBX1325 Phase 1 ResultsN/A
2021-07-22 05:30 ESTNewsUnity Biotech perks up on positive data from early-stage trial for eye diseaseN/A
2021-04-08 17:31 ESTNewsOur First Take On Unity BiotechnologyN/A
2021-02-16 17:24 ESTNewsUnity Biotechnology cut to sell at Citi on valuationN/A
2021-02-16 08:35 ESTAnalyst RatingThe Analyst Target Price has increased from $5.67 to $5.83.Neutral
2021-02-10 20:16 ESTNewsUnity shares surge 9% premarket on age-related eye diseases discoveryN/A
2020-11-28 07:15 ESTNewsA Look Inside Unity Biotechnology's Transition To An Ophthalmology CompanyN/A
2020-11-26 21:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 17:48 ESTNewsUnity Biotechnology EPS misses by $0.10N/A
2020-11-05 09:05 ESTEarnings EstimateAn EPS average of -$0.39 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-12 17:42 ESTNewsDosing underway for Unity Biotech's UBX1325 in early-stage diabetic macular edema studyN/A
2020-09-26 14:22 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 02:54 ESTNewsUnity to slash headcount by ~30%; keeps focus on eye drug candidateN/A
2020-09-16 02:54 ESTNewsUnity Biotechnology Inc (UBX) Investor Presentation - SlideshowN/A
2020-09-15 21:29 ESTInsider TradeJamie Dananberg has directly acquired 240,000 shares and currently holds 692,219 shares.Buy
2020-09-15 21:29 ESTInsider TradeAnirvan Ghosh has directly acquired 300,000 shares and currently holds 600,000 shares.Buy

About Unity Biotechnology, Inc (UBX):

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 that is in Phase II clinical trial for musculoskeletal/ osteoarthritis disease, as well as Phase Ib clinical trial for moderate-to-severe osteoarthritis of the knee; UBX1325, which is Phase I clinical trial for the treatment of diabetic macular edema; and UBX1967 for the treatment of ophthalmologic diseases. It is also developing programs in pulmonary disorders and neurological disorders, as well as kidney and liver diseases. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in South San Francisco, California.

UBX Quotes by TradingView

See Advanced Chart

General

  • Name Unity Biotechnology, Inc
  • Symbol UBX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 76
  • Fiscal Year EndDecember
  • IPO Date2018-05-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.unitybiotechnology.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 3.76
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.51
  • Return on Assets -38%
  • Return on Equity -87%
  • Earnings Per Share -$1.97
  • Revenue Per Share $0
  • Gross Profit -70957000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 351.87 million
  • EBITDA -82154000
  • Analyst Target Price $5.83
  • Book Value Per Share $1.86
View More

Share Statistics

  • Shares Outstanding 52.91 million
  • Shares Float 38.1 million
  • % Held by Insiders 1180%
  • % Held by Institutions 56.5%
  • Shares Short 2.12 million
  • Shares Short Prior Month 2.42 million
  • Short Ratio 2.08
  • Short % of Float 6%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 0.33
  • 52 Week High $12.46
  • 52 Week Low $2.72
  • 50 Day Moving Average 7.18
  • 200 Day Moving Average 5.37
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Unity Biotechnology, Inc (UBX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Unity Biotechnology, Inc (UBX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-04$N/A-$0.52-$0.45-14.49%
2020-06-302020-07-31$N/A-$0.36-$0.5130.07%
2020-03-312020-05-07$N/A-$0.55-$0.51-7.65%
2019-12-312020-03-11$N/A-$0.39-$0.5629.69%
2019-09-302019-11-06$N/A-$0.51-$0.534.17%
2019-06-302019-08-07$N/A-$0.56-$0.49-15.42%
2019-03-312019-05-08$N/A-$0.47-$0.516.54%
2018-12-312019-03-06$N/A-$0.48-$0.43-11.3%
2018-09-302018-11-07$N/A-$0.46-$0.41-11.69%
2018-06-302018-08-09$N/A-$0.69-$0.47-47.41%
2018-03-312018-06-07$N/A-$4.69-$1.00-367.5%

Unity Biotechnology, Inc (UBX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A N/A 70.96 million N/A
Income Before Tax N/A N/A N/A -18.03 million -21.71 million
Selling General Administrative N/A N/A N/A 4.91 million 5.69 million
Gross Profit N/A N/A N/A 52.75 million -17.78 million
Ebit N/A N/A N/A -23.11 million -23.47 million
Operating Income N/A N/A N/A -23.11 million -23.47 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A -52.75 million 17.78 million
Total Other Income Expense Net N/A N/A N/A 5.09 million 1.76 million
Net Income From Continuing Operations N/A N/A N/A -18.03 million -21.71 million
Net Income Applicable to Common Shares -27.55 million -18.67 million -28.04 million -18.03 million -21.71 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A -3.86 million 25.62 million
Change to Liabilities 296000 83000 -1.35 million 104000 -722000
Total Cash Flow from Investing Activities -6.61 million 12.31 million 3.67 million -4.47 million 25.08 million
Net Borrowings 24.92 million -38000 N/A -21000 -16000
Total Cash Flow from Financial Activities N/A N/A N/A 20.87 million 5.41 million
Change to Operating Activities 3.89 million -1.62 million -3.63 million 3.45 million 2.92 million
Change in Cash N/A N/A N/A 705000 13.66 million
Total Cash from Operating Activities -17.26 million -19.28 million -25.07 million -15.69 million -16.83 million
Depreciation N/A N/A N/A 343000 235000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities -416000 75000 -19000 N/A N/A
Change to Net Income 5.15 million 5000 7.04 million -1.56 million 2.44 million
Capital Expenditures N/A N/A N/A 609000 540000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 76.87 million N/A N/A 30.51 million 26.96 million
Total Stockholder Equity 98.1 million N/A N/A 120.71 million 114.72 million
Other Current Liabilities N/A N/A N/A 1.13 million 1.16 million
Total Assets 174.97 million N/A N/A 151.22 million 141.68 million
Common Stock 5000 5000 5000 5000 4000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -319.71 million -292.16 million -273.49 million -245.46 million -227.43 million
Other Liabilities N/A N/A N/A 13.3 million 12.64 million
Other Assets 1.45 million 2.04 million 2.04 million 2.07 million 3.09 million
Cash 48.58 million N/A N/A 37.47 million 36.77 million
Total Current Liabilities 16.93 million N/A N/A 17.22 million 14.32 million
Other Stockholder Equity -144000 -340000 -255000 -538000 -506000
Property, Plant & Equipment 37.83 million 39.12 million 40.51 million 16.64 million 5.36 million
Total Current Assets 135.69 million N/A N/A 129.49 million 125.87 million
Long Term Investments N/A N/A N/A 3.03 million 7.35 million
Net Tangible Assets 98.1 million 112.26 million 105.33 million 120.71 million 114.72 million
Short Term Investments 83.63 million N/A N/A 90.02 million 76.21 million
Long Term Debt 24.31 million N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.26 million N/A N/A 5.19 million 4.58 million

Unity Biotechnology, Inc (UBX) Chart:

Unity Biotechnology, Inc (UBX) News:

Below you will find a list of latest news for Unity Biotechnology, Inc (UBX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Unity Biotechnology, Inc (UBX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710.5CALL0 200TRUE00
2024-05-1720.05CALL6 409134.43FALSE0.050
2024-05-1730.15CALL0 750FALSE00
2024-05-1740.15CALL0 650FALSE00
2024-05-1750.05CALL0 430FALSE00
2024-05-1760.1CALL0 80FALSE00
2024-05-1710.1PUT0 10FALSE00
2024-05-1720.45PUT0 1100TRUE00
2024-05-1731.2PUT0 0575.34TRUE00
2024-05-1742.19PUT0 2768.56TRUE00
2024-05-1750PUT0 0528.46TRUE00
2024-05-1760PUT0 00TRUE00
2024-06-2110.9CALL6 2304.93TRUE0.90
2024-06-2120.75CALL0 30FALSE00
2024-06-2130CALL0 00FALSE00
2024-06-2140CALL0 00FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120PUT0 00TRUE00
2024-06-2130PUT0 0576.46TRUE00
2024-06-2140PUT0 0594.02TRUE00
2024-06-2150PUT0 0223.88TRUE00
2024-08-1610.7CALL0 230470.83TRUE00
2024-08-1620.2CALL10 10093.29FALSE0.20
2024-08-1630.05CALL0 860FALSE00
2024-08-1640.1CALL0 40FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-1660CALL0 00FALSE00
2024-08-1610PUT0 00FALSE00
2024-08-1620.52PUT0 896.54TRUE00
2024-08-1631.35PUT0 2126.42TRUE00
2024-08-1640PUT0 0125.78TRUE00
2024-08-1650PUT0 0336.7TRUE00
2024-08-1660PUT0 0649.19TRUE00
2024-11-1510.85CALL0 11493.89TRUE00
2024-11-1520.2CALL0 41961.26FALSE00
2024-11-1530.15CALL0 115175.21FALSE00
2024-11-1540.05CALL0 20FALSE00
2024-11-1550CALL0 00FALSE00
2024-11-1510PUT0 00FALSE00
2024-11-1520.75PUT0 1100.39TRUE00
2024-11-1530PUT0 0159.07TRUE00
2024-11-1540PUT0 0158.34TRUE00
2024-11-1550PUT0 0188.73TRUE00

Latest UBX Trades:

Date Shares Price
Jun 13, 2022 7:54 PM EST100$0.6349
Jun 13, 2022 7:55 PM EST100$0.6349
Jun 13, 2022 7:56 PM EST100$0.6349
Jun 13, 2022 7:58 PM EST100$0.6359
Jun 13, 2022 7:58 PM EST97$0.6365

Unity Biotechnology, Inc (UBX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020031499/0001564590-20-031499-index.htm
2019-06-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1463361/000000000019009336/0000000000-19-009336-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000031506619000757/0000315066-19-000757-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000031506619000762/0000315066-19-000762-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000031506620001233/0000315066-20-001233-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924318026655/0000899243-18-026655-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924318030039/0000899243-18-030039-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924318030040/0000899243-18-030040-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924319024071/0000899243-19-024071-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924319024072/0000899243-19-024072-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924319024073/0000899243-19-024073-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924319024074/0000899243-19-024074-index.htm
2020-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320004324/0000899243-20-004324-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320005933/0000899243-20-005933-index.htm
2020-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009844/0000899243-20-009844-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009846/0000899243-20-009846-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009848/0000899243-20-009848-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009850/0000899243-20-009850-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009854/0000899243-20-009854-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009855/0000899243-20-009855-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320009866/0000899243-20-009866-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320015822/0000899243-20-015822-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017383/0000899243-20-017383-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017388/0000899243-20-017388-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017390/0000899243-20-017390-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017393/0000899243-20-017393-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017394/0000899243-20-017394-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017396/0000899243-20-017396-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017397/0000899243-20-017397-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017398/0000899243-20-017398-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017552/0000899243-20-017552-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017553/0000899243-20-017553-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017554/0000899243-20-017554-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017555/0000899243-20-017555-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017556/0000899243-20-017556-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320017558/0000899243-20-017558-index.htm
2020-08-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320021183/0000899243-20-021183-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320021189/0000899243-20-021189-index.htm
2020-09-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320025179/0000899243-20-025179-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320025180/0000899243-20-025180-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320025182/0000899243-20-025182-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320025185/0000899243-20-025185-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000089924320025187/0000899243-20-025187-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000107261319000104/0001072613-19-000104-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000107261320000097/0001072613-20-000097-index.htm
2019-01-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000108887519000016/0001088875-19-000016-index.htm
2020-02-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000108887520000045/0001088875-20-000045-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000110465919008697/0001104659-19-008697-index.htm
2018-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021464/0001140361-18-021464-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021807/0001140361-18-021807-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021808/0001140361-18-021808-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021810/0001140361-18-021810-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021811/0001140361-18-021811-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021813/0001140361-18-021813-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021815/0001140361-18-021815-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021817/0001140361-18-021817-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021820/0001140361-18-021820-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021823/0001140361-18-021823-index.htm
2018-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118021826/0001140361-18-021826-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022043/0001140361-18-022043-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022044/0001140361-18-022044-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022045/0001140361-18-022045-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022046/0001140361-18-022046-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022047/0001140361-18-022047-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022048/0001140361-18-022048-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022049/0001140361-18-022049-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000114036118022050/0001140361-18-022050-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1463361/000114036119007742/0001140361-19-007742-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1463361/000114036119007743/0001140361-19-007743-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1463361/000114036120009703/0001140361-20-009703-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1463361/000114036120009706/0001140361-20-009706-index.htm
2018-05-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1463361/000119312518151267/0001193125-18-151267-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312518154514/0001193125-18-154514-index.htm
2018-05-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1463361/000119312518154668/0001193125-18-154668-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312518186922/0001193125-18-186922-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000119312519033722/0001193125-19-033722-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000119312519035942/0001193125-19-035942-index.htm
2019-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1463361/000119312519163547/0001193125-19-163547-index.htm
2019-06-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1463361/000119312519165134/0001193125-19-165134-index.htm
2019-06-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1463361/000119312519168282/0001193125-19-168282-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312519189296/0001193125-19-189296-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312519299455/0001193125-19-299455-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1463361/000119312520031546/0001193125-20-031546-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520047291/0001193125-20-047291-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520059226/0001193125-20-059226-index.htm
2020-07-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1463361/000119312520205400/0001193125-20-205400-index.htm
2020-07-318-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520205405/0001193125-20-205405-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520209313/0001193125-20-209313-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520222493/0001193125-20-222493-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520236397/0001193125-20-236397-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520247236/0001193125-20-247236-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000119312520253423/0001193125-20-253423-index.htm
2018-06-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459018015253/0001564590-18-015253-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459018021025/0001564590-18-021025-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459018021036/0001564590-18-021036-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459018028001/0001564590-18-028001-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459018028024/0001564590-18-028024-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459018030483/0001564590-18-030483-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019000113/0001564590-19-000113-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019006393/0001564590-19-006393-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1463361/000156459019006397/0001564590-19-006397-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1463361/000156459019006399/0001564590-19-006399-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019017183/0001564590-19-017183-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459019017198/0001564590-19-017198-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019023220/0001564590-19-023220-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019027060/0001564590-19-027060-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019030046/0001564590-19-030046-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459019030066/0001564590-19-030066-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459019041000/0001564590-19-041000-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459019041014/0001564590-19-041014-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020010059/0001564590-20-010059-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1463361/000156459020010071/0001564590-20-010071-index.htm
2020-03-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1463361/000156459020010078/0001564590-20-010078-index.htm
2020-03-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1463361/000156459020014179/0001564590-20-014179-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020014273/0001564590-20-014273-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020022843/0001564590-20-022843-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459020022861/0001564590-20-022861-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020030446/0001564590-20-030446-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020031499/0001564590-20-031499-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020031851/0001564590-20-031851-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020035033/0001564590-20-035033-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459020035035/0001564590-20-035035-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1463361/000156459020050461/0001564590-20-050461-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1463361/000156459020050497/0001564590-20-050497-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013725/0001567619-19-013725-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013863/0001567619-19-013863-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013864/0001567619-19-013864-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013866/0001567619-19-013866-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013870/0001567619-19-013870-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013872/0001567619-19-013872-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013875/0001567619-19-013875-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013877/0001567619-19-013877-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013880/0001567619-19-013880-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013882/0001567619-19-013882-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013884/0001567619-19-013884-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013885/0001567619-19-013885-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013892/0001567619-19-013892-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1463361/000156761919013893/0001567619-19-013893-index.htm
2018-05-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1463361/999999999518001103/9999999995-18-001103-index.htm
2019-06-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1463361/999999999519001299/9999999995-19-001299-index.htm
2018-05-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1463361/999999999718005484/9999999997-18-005484-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1463361/999999999719002062/9999999997-19-002062-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1463361/999999999720000301/9999999997-20-000301-index.htm

Unity Biotechnology, Inc (UBX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Unity Biotechnology, Inc (UBX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1180%
Institutional Ownership: 5650%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-10-10II Robert C. GoeltzChief Financial OfficerBuy5,000.003.4317,150.00101,348.00https://www.sec.gov/Archives/edgar/data/1463361/000089924318026655/0000899243-18-026655-index.htm
2019-06-20II Robert C. GoeltzChief Financial OfficerBuy21,075.00124,404.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013880/0001567619-19-013880-index.htm
2020-02-24II Robert C. GoeltzChief Financial OfficerBuy10,000.003.4334,300.00134,404.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320005933/0000899243-20-005933-index.htm
2020-09-13Alexander AzoyOfficerBuy135,000.00135,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320025180/0000899243-20-025180-index.htm
2020-03-30Anirvan GhoshChief Executive OfficerBuy120,000.00150,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009866/0000899243-20-009866-index.htm
2020-03-30II Robert C. GoeltzChief Financial OfficerBuy29,106.00163,510.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009854/0000899243-20-009854-index.htm
2019-06-19Keith R LeonardChief Executive OfficerBuy20,000.003.4068,000.00170,782.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013725/0001567619-19-013725-index.htm
2019-06-20Tamara TompkinsOfficerBuy21,075.0021,075.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013885/0001567619-19-013885-index.htm
2019-06-20Keith R LeonardChief Executive OfficerBuy40,000.00210,782.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013875/0001567619-19-013875-index.htm
2019-06-20Nathaniel E DavidPresidentBuy21,075.002,299,731.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013877/0001567619-19-013877-index.htm
2020-03-30Nathaniel E DavidPresidentBuy24,255.002,323,986.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009850/0000899243-20-009850-index.htm
2020-06-05Nathaniel E DavidPresidentBuy3,200.008.9028,478.082,327,186.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320015822/0000899243-20-015822-index.htm
2020-09-13Lynne Marie SullivanChief Financial OfficerBuy240,000.00240,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320025187/0000899243-20-025187-index.htm
2020-03-30Anirvan GhoshChief Executive OfficerBuy30,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009866/0000899243-20-009866-index.htm
2020-03-30Anirvan GhoshChief Executive OfficerBuy150,000.00300,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009866/0000899243-20-009866-index.htm
2019-06-20Dan MarquessChief Scientific OfficerBuy21,075.00357,041.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013884/0001567619-19-013884-index.htm
2020-03-30Dan MarquessChief Scientific OfficerBuy24,255.00381,297.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009848/0000899243-20-009848-index.htm
2019-06-20Jamie DananbergChief Medical OfficerBuy21,075.00430,447.00https://www.sec.gov/Archives/edgar/data/1463361/000156761919013882/0001567619-19-013882-index.htm
2020-03-30Tamara TompkinsOfficerBuy24,255.0045,330.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009855/0000899243-20-009855-index.htm
2020-03-30Jamie DananbergChief Medical OfficerBuy24,255.00454,702.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320009846/0000899243-20-009846-index.htm
2020-09-13Anirvan GhoshChief Executive OfficerBuy300,000.00600,000.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320025185/0000899243-20-025185-index.htm
2020-09-13Jamie DananbergChief Medical OfficerBuy240,000.00692,219.00https://www.sec.gov/Archives/edgar/data/1463361/000089924320025182/0000899243-20-025182-index.htm